Head & Neck Cancer section

Head and Neck Cancer News & Features

Erythropoietin plus radiation does not improve local-regional control in anemic patients with head and neck cancer

The addition of erythropoietin did not improve local-regional control for anemic patients with head and neck squamous cell carcinoma (HNSCC) who receive radiation therapy.

Written Education Tool Improves Patient Satisfaction with Microvascular Reconstruction

Written Education Tool Improves Patient Satisfaction with Microvascular Reconstruction

Head and neck cancer patients prefer a written educational tool that addresses questions and concerns prior to microvascular reconstruction.

Likelihood not to return to work after head and neck cancer treatment is high

Likelihood not to return to work after head and neck cancer treatment is high

Current unemployment for head and neck cancer survivors linked to harder physical work, surgical treatment, and risky alcohol consumption.

About 40 percent of head and neck cancer survivors do not return to work

About 40 percent of head and neck cancer survivors do not return to work

Many survivors of head and neck cancer do not return to work.

Engineered immune cells could improve outcomes in nasopharyngeal carcinoma

A new method of genetically engineering immune cells could lead to improved treatment of patients with nasopharyngeal carcinoma (NPC).

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs